Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma

Renal cell carcinoma (RCC) is a common malignancy worldwide with approximately 95,000 new cases per year and ranks as the sixth cause of cancer deaths. Until recently, the slightly active and very toxic cytokines were available for patients with advanced RCC. Advances have been made in understanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Zustovich, Fable, Lombardi, Giuseppe, Pastorelli, Davide, Farina, Patrizia, Bianco, Massimo Dal, De Zorzi, Luca, Palma, Maurizia Dalla, Nicoletto, Ornella, Zagonel, Vittorina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818940/
https://www.ncbi.nlm.nih.gov/pubmed/24198638
http://dx.doi.org/10.2147/OAJU.S7230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818940/
https://www.ncbi.nlm.nih.gov/pubmed/24198638
http://dx.doi.org/10.2147/OAJU.S7230

Ejemplares similares